Trailing-twelve-month (TTM) revenue is $108.95 Million with a year-over-year growth of +14.28%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $26,405,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-20 |
| Q4 FY2025Period ended 2025-12-31 | $28,387,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-25 |
| Q1 FY2026Period ended 2026-03-31 | $26,425,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-12 |
| Q2 FY2026Period ended 2026-06-30 | $27,737,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-12 |
| TTM revenue | $108,954,000 |
Current P/S: $408,018,654 market capitalization ÷ $108,954,000 TTM revenue = 3.74x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $27.74M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:05:40.747Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| Product | $61M | $38M | $30M | $31M |
| Service | $62M | $56M | $62M | $71M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20162016-12-31 · USD | FY20172017-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | N/A | $16M | $22M | $17M | $14M | $19M |
| Americas (excluding the United States) | $13M | N/A | N/A |
$108.95M
$108.95 Million
+14.28%
vs. $95.34M a year ago (TTM)
(4.93%)
5 Year compound annual growth rate
1 Year
+14.28%
3 Year
+1.48%
5 Year
(4.93%)
10 Year
+1.41%
15 Year
+3.34%
20 Year
+7.05%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $101.99M | +$9.80M | +10.63% |
| 2024 | $92.19M | ($955,000) | (1.03%) |
| 2023 | $93.15M | ($29.59M) | (24.11%) |
| 2022 | $122.74M | ($22.86M) | (15.70%) |
| 2021 | $145.60M | +$9.68M | +7.12% |
| 2020 |
TTM Growth
+14.28%
3-Year CAGR
+1.48%
5-Year CAGR
(4.93%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:05:40.747Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| Asia And Oceania | $28M | $14M | $30M | $21M | $24M | $19M |
|---|
| Europe | $34M | $40M | $42M | $40M | $35M | $44M |
|---|
| ISRAEL | N/A | N/A | N/A | $1,000 | N/A | N/A |
|---|
| Middle East And Africa | $12M | $12M | $29M | $16M | $19M | $20M |
|---|
| United States | $3M | N/A | N/A | N/A | N/A | N/A |
|---|
| $135.92M |
| +$25.82M |
| +23.45% |
| 2019 | $110.10M | +$14.26M | +14.88% |
| 2018 | $95.84M | +$13.85M | +16.89% |
| 2017 | $81.99M | ($8.38M) | (9.27%) |
| 2016 | $90.37M | ($9.60M) | (9.60%) |
